Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania
© Mmbando et al; licensee BioMed Central Ltd. 2009
Received: 26 February 2009
Accepted: 18 July 2009
Published: 18 July 2009
Site preparation is a pre-requesite in conducting malaria vaccines trials. This study was conducted in 12 villages to determine malariometric indices and associated risk factors, during long and short rainy seasons, in an area with varying malaria transmission intensities in Korogwe district, Tanzania. Four villages had passive case detection (PCD) of fever system using village health workers.
Four malariometric cross-sectional surveys were conducted between November 2005 and May 2007 among individuals aged 0–19 years, living in lowland urban, lowland rural and highland strata. A total of 10,766 blood samples were collected for malaria parasite diagnosis and anaemia estimation. Blood smears were stained with Giemsa while haemoglobin level was measured by HaemoCue. Socio-economic data were collected between Jan-Apr 2006.
Adjusting for the effect of age, the risk of Plasmodium falciparum parasitaemia was significantly lower in both lowland urban, (OR = 0.26; 95%CI: 0.23–0.29, p < 0.001) and highlands, (OR = 0.21; 95%CI: 0.17–0.25, p < 0.001) compared to lowland rural. Individuals aged 6–9 years in the lowland rural and 4–19 years in both lowland urban and highlands had the highest parasite prevalence, whilst children below five years in all strata had the highest parasite density. Prevalence of splenomegaly and gametocyte were also lower in both lowland urban and highlands than in lowland rural. Anaemia (Hb <11 g/dl) prevalence was lowest in the lowland urban. Availability of PCD and higher socio-economic status (SES) were associated with reduced malaria and anaemia prevalence.
Higher SES and use of bed nets in the lowland urban could be the important factors for low malaria infections in this stratum. Results obtained here were used together with those from PCD and DSS in selecting a village for Phase 1b MSP3 vaccine trial, which was conducted in the study area in year 2008.
Malaria remains a major cause of morbidity and mortality in sub-Saharan Africa . Worldwide malaria morbidity is estimated to be 300–500 million cases and about 1 million deaths each year, of which 90% occur in sub-Saharan Africa [2, 3]. The vast majority of deaths occur among children below five years of age and pregnant women, especially in remote rural areas with poor access to health services .
In many parts of the world, adequate treatment of malaria is becoming increasingly difficult due to worsening problems of drug resistance, which have rendered cheap drugs such as chloroquine and sulphadoxine/pyrimethamine ineffective [5, 6]. Hence, prevention of malaria by vaccines is perceived as a tool that will compliment currently available strategies for malaria control . With more malaria vaccine candidates becoming available [7, 8], a suitable chosen area with detailed epidemiological information is required for testing and evaluating different trial endpoints [1, 9]. The site needs to be prepared and should focus on characterising the population (eg size, structure), accessibility of the site, availability of health services and malaria burden in the area. Site preparation involving local communities is also likely to reduce ethical issues which could otherwise compromize implementation of the trials .
In 2004, the African Malaria Network Trust (AMANET) received a grant from AIDCO, which, among other things, was to support capacity strengthening of selected African Research institutions to be able to conduct malaria vaccine trials. Site characterization for future trial sites was one of the most important components of the grant. The National Institute for Medical Research at its Centre based in Tanga, Tanzania, was one of the beneficiaries of the sub-grants given by AMANET. One of the objectives of the project was thus to conduct repeated malariometric surveys in 12 villages to describe distribution of malaria parasites as well as anemia and splenomegaly. This was done during short and long rainy seasons in urban and rural areas of Korogwe district between November 2005 and May 2007. Results from this study were used together with other data to provide guidance in the selection of villages suitable for conducting malaria vaccines
Study area and population
The study was conducted in 12 villages of Korogwe district, Tanga region, north-eastern Tanzania. The population of Korogwe district was estimated to be 261,004 in 2002, with a growth rate of 1.4% per annum . The district has 47 dispensaries, four health centres and two hospitals. Korogwe district can be topographically stratified into lowland and highlands zones, with altitudes ranging from 300–1,200 meters above sea level (mASL). Malaria transmission in these areas decreases with increasing altitude and varies within a short distance [12–14]. In both zones, malaria transmission is highest during and following the long rainy season, which usually extends from March through July . Low transmission is experienced during short rains (October – December).Anopheles gambiae s.s and Anopheles funestus are the main vectors of malaria . Plasmodium falciparum is the predominant malaria species accounting for more than 90% of all infections, the rest being Plasmodium malariae and Plasmodium ovale .
The study involved four cross sectional malariometric surveys which were conducted during short rains in November/December 2005 and 2006, and long rains in May/June 2006 and 2007. The study involved individuals aged 0–19 years who were randomly selected from the census database during the first baseline survey. Prior to the study, a population census was conducted in October/November 2005 followed by demographic surveillance system (DSS) follow ups which are being implemented since January 2006. Population of individuals below 20 years was estimated to be 5400, lowlands rural, 6200 lowland urban and 2100 in the highlands. A socio-economic survey was conducted as part of the DSS between January and May 2006. The sample size was calculated based on population survey design in each stratum. At 95% confidence interval and 80% power, a sample size required was 985, 1130 and 385 in rural lowland, lowland urban and highlands, respectively. A list of individuals to participate in the surveys was randomly generated from the census database.
Ethical clearance was granted by the Medical Research Co-ordinating Committee of the National Institute for Medical Research, Tanzania. Prior to the study, sensitization meetings were held in each village to explain the objectives and methodology of the study as well as seeking for community consent. Informed consent was obtained both orally and in writing from all individual participants or parents/guardians in case of children during the survey.
Clinical examination, blood collection and laboratory analysis
Demographic information of each selected individual including name, sex, age and village of residence were recorded on a morbidity questionnaire. Thereafter, clinical and physical examination was done to assess participant's general clinical condition. Assessment of spleen enlargement was done according to Hackett's classification. Axillary temperature was measured using electronic thermometer. Individuals found to be sick were treated appropriately or referred to the nearby health facilities depending on the patients' clinical condition.
A blood sample was collected for thick and thin smears preparation for malaria parasite quantification and identification, haemoglobin estimation and for other bioassays. Haemoglobin levels were estimated using HemoCue machine (HemoCue, Ångelholm, Sweden). Blood smears were stained with Giemsa and asexual parasites were counted against 200 white blood cells (WBCs) while sexual parasites were counted against 500 WBCs. A blood slide was declared negative after reading 100 high power fields. For quality control, 10% of the blood smears were randomly selected and read by another microscopist. Smears with discordant results were re-read by a third microscopist. Results of two microscopists with difference of less than 20% were adopted according to the standard operating procedures.
Data management and analysis
Data were double entered and verified in Microsoft Access, while consistence checks and analyses were done using STATA software version 8.0 (StataCorp LP, TX, USA). Principal component analysis (PCA) was used to categorize households into different socio-economic scores. Household scores were grouped into three categories at ratios 40:40:20 as low, medium and high SES's . Variable which were considered in the PCA were: type and material used to build the house, source of power for lighting and cooking, ownership of radio, bicycle and mobile phone, ratio of number of sleeping bedrooms and bed nets to number of household dwellers, occupation of head of household as well as number of animal and size of land owned or cultivated by the family. About 50% of individuals had two or more observations in the four surveys and, therefore, generalized estimating equation (GEE) with robust standard errors was used to assess risk factors associated with the response variables. Response variables modeled using GEE were prevalence of parasitaemia, anaemia (<11 g/dl), splenomegaly, gametocytes and mean haemoglobin concentration (g/dl). Haemoglobin concentration was adjusted for the physiological effect of oxygen-carrying capacity as a result of the increase in altitude . Parasite counts/200WBC were converted into parasites/μL by multiplying by 40, assuming that 1 μL of blood (of a physiologically normal person) contains 8,000 WBCs, and the counts were transformed to normal using natural logarithm. Anaemia was defined as Hb <11 g/dl whilst splenomegaly was referred to as presence of any enlarged spleen detectable during physical examination. Data from similar season (short or long rains) were pooled during analysis. P-value below 0.05 was considered significant.
Characteristics of study villages and malariometric indices of individuals sampled into surveys done during short and long rain seasons, Nov/Dec 2005 – May/Jun 2007.
Strata, village name (observations)
Altitude, mean (range), m
Median SES score (IQR)
Median age (IQR), years
Bed net use, %
Parasite prevalence, %
Lowlands rural (4,434)
Magunga cheke (566)
0.28 (-0.34, 0.78)
-0.11 (-0.53, 0.33)
0.1 6(-0.45, 0.59)
-0.51 (-1.08, -0.11)
-0.56 (-1.38, 0.30)
-0.37 (-1.01, 0.17)
Lowlands urban (4,446)
1.38 (0.73, 1.96)
0.58 (-0.14, 1.26)
-0.04 (-0.60, 0.61)
-0.78 (-1.29, -0.27)
-0.91 (-1.44, -0.15)
-0.59 (-1.03, -0.03)
Malaria parasite prevalence and density
Odds ratios for risk factors associated with presence of P. falciparum adjusted for effect of age in each stratum.
bed net use
bed net use
bed net use
Overall gametocyte prevalence was highest (4.2%) in lowland rural. In lowland urban and highlands it was 1.2% and 1.3%, respectively. Regression analysis showed lower risk of gametocytaemia in both lowland urban, (OR = 0.367; 95%CI: 0.266–0.505, p < 0.001) and highlands, (OR = 0.383; 95%CI: 0.245–0.600, p < 0.001) compared to lowland rural. The odd ratio of gametocytaemia in individuals from medium and low compared to high SES households were 2.58 (95%CI: 1.59–4.19) and 2.62 (95%CI: 1.58–4.35), respectively. In villages with PCD, the carriage rate was significantly low, (OR = 0.675; 95%CI: 0.472–0.965, P = 0.031). There was no seasonal variation in gametocyte rates.
Prevalence of splenomegaly during the long rains was 16.5%, 5.3% and 3.5% while in short rain season was 19.1%, 3.9% and 5.0% in lowland rural, lowland urban and highlands, respectively; and there was no difference between the two seasons. Similarly, lower risk was observed in individuals who were using bed nets, OR = 0.62 (95%CI: 0.54–0.71, p < 0.001) and in villages with PCD, OR = 0.42 (95%CI: 0.34–.51, p < 0.001) while higher risk was seen in low SES, OR = 1.82 (95%CI: 1.43–2.32, p < 0.001) and medium SES, OR = 2.29 (95%CI: 1.78– 2.94, p < 0.001).
Haemoglobin levels and anaemia prevalence
Coefficients and odds ratios for risk factors associated with variation in mean Hb concentration (g/dL) and anaemia (Hb <11 g/dL) status in the study villages during four malariometric surveys.
Hb concentration, g/dl
Anaemia, Hb <11 g/dl
bed net use
A similar pattern as that of mean Hb was seen for variables associated with risk of anaemia (Table 3). Variables that were associated with increase in mean Hb were also associated with decrease in anaemia prevalence and vice versa, except the use of bed nets which had no effect on the prevalence of anaemia.
This epidemiological study was designed to obtain data on malariometric indices in villages with different malaria transmission intensities during short and long rainy seasons in Korogwe district, north-eastern Tanzania. It was aimed at providing baseline epidemiological information needed in selection of areas for implementing malaria clinical trials and involved both rural and urban settings.
Parasite prevalence is considered as the easiest way of measuring malaria transmission compared to entomological and serology measures. However, it is more affected by seasonal variation in transmission levels, survey timing, and peak transmission seasons, and hence can be seen as reliable within a short time interval . Unlike serology measures which can capture long term transmission  and entomological measures which at some points is not possible because of low transmission , parasitological measure can be used to assess change in transmission. Data presented here shows that malaria prevalence was lower in the highlands and lowland urban strata, and that the malaria transmission levels were similar in the two strata. Taken together, prevalence data on all malariometric indices and mild anaemia (Hb <11 g/dl), seen in this study, provided a good estimate of malaria endemicity in the three strata.
Previous studies in Korogwe have reported a decrease in malaria with increase in altitude [12, 13, 17]. However, this study is the first to provide data on malaria epidemiology in a lowland urban area of Korogwe, which found low malaria parasite prevalence and splenomegaly in this stratum when compared to the lowland rural. The low malaria transmisison in lowland urban stratum as shown by low parasite prevalence, splenomegaly, gametocyte carriage, and anaemia could be due to better social economic status, higher bed net coverage and access to better health care. Better houses and access to bed nets provide urban population with reliable means of protection from mosquito bites which cannot be easily accessed by poor communities from rural villages [21, 22]. This indicates that the urban population might be exposed to low density of infected mosquitoes per person and therefore these villages have low malaria transmission intensity despite being located in the lowland [23–25].
In the present study, the finding of peak malaria parasite prevalence in children aged 6–9 years in lowland rural, while in lowland urban and highlands it was high in all individuals aged 4–19 years, suggests better immunity in the lowland rural and thus higher exposure to mosquito bites and malaria infection. Notwithstanding this, children below 5 years had the highest parasite density in all strata indicating immature immunity and higher vulnerability to malaria. As expected, children in the low malaria risk area of lowland urban had lowest parasite density. The observation of lack of seasonal variation in prevalence of gametocytes and splenomegaly seems to suggest similar transmission dynamics during short and long rains in the 2 year study period. Furthermore, the significantly higher malaria parasite prevalence observed in lowland rural during the short rains could be due to increased rainfall in October/November 2006.
Data from this study found significant variation in malaria transmission within a short distance; and this might have a bearing on malaria diagnosis and management. Findings from this study suggest that trials aimed at higher malaria transmission areas should focus in the rural areas where socio-economic status is low. And socio-economic status remains an important risk factor for malaria transmission, and so efforts to combat malaria should also focus on socio-economic status of the communities.
This study has documented low level of malaria infections (prevalence, gametocyte carriage, splenomegaly and anaemia) in the lowland urban villages, which could be due to different factors; some of which could not be fitted or explained in this paper and therefore needs more exploration. Use of sensitive PCR methods for detection of asexual and sexual parasites to rule out sub-microscopic parasitaemia is recommended. Effect of PCD in the area was found to have led to a significant reduction in prevalence of both asexual and sexual forms of P. falciparum as well as increasing mean Hb concentration. Data from this study and others on the immunology of malaria (Segeja et al submitted for publication), DSS, and PCD were used in the selection of a study site for a Phase Ib malaria vaccine trial of MSP3 (Lusingu et al, in press). The data will also be useful in planning and implementing other trials in Korogwe district, such as a Phase 3 of RTS,S vaccine trial.
passive case detection
community resource person(s)
meters above sea level; % percent
African Malaria Network Trust
merozoite surface protein 3
demographic surveillance system
generalized estimating equation
artemisinin-based combination therapy
polymerase chain reaction
Centre for Medical Parasitology
Joint Malaria Programme
National Malaria Control Programme
National Institute for Medical Research
Ministry of Health and Social Welfare
ninety five percent confidence interval
grams per decilitre
Geometric mean parasite density
We thank all individuals who agreed to participate in the study and the villages leadership for their cooperation. We would like to acknowledge excellent technical support by Ezekiel Malecela, Rashidi Madebe, Juma Akida, Malimi Chille, Johari Sadi, Magreth Munisi, Zaina Maumba, Hatibu Athumani and Juma Tupa. Thanks to Zahabu Kauzeni, Thomas Semdoe and Allen Mrango for driving the field teams. We thank research and support teams from Tanga Centre. Thanks to Prof WL Kilama and Dr R Chilengi of AMANET, CMP and other JMP partners, Korogwe district authorities, NMCP, NIMR and MoHSW. The study was financed by a grant from the African Malaria Network Trust (AMANET)
- Kilama WL: Malaria vaccines in Africa. Acta Trop. 2003, 88: 153-159. 10.1016/S0001-706X(03)00200-6.View ArticlePubMedGoogle Scholar
- Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038/nature03342.PubMed CentralView ArticlePubMedGoogle Scholar
- Suh KN, Kain KC, Keystone JS: Malaria. CMAJ. 2004, 170: 1693-1702.PubMed CentralView ArticlePubMedGoogle Scholar
- Kahigwa E, Schellenberg D, Sanz S, Aponte JJ, Wigayi J, Mshinda H, Alonso P, Menendez C: Risk factors for presentation to hospital with severe anaemia in Tanzanian children: a case-control study. Trop Med Int Health. 2002, 7: 823-830. 10.1046/j.1365-3156.2002.00938.x.View ArticlePubMedGoogle Scholar
- Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope?. Bull World Health Organ. 2000, 78: 1378-1388.PubMed CentralPubMedGoogle Scholar
- Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC: High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996, 90: 179-181. 10.1016/S0035-9203(96)90129-7.View ArticlePubMedGoogle Scholar
- Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garcon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J: Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine. 2005, 23: 2243-2250. 10.1016/j.vaccine.2005.01.142.View ArticlePubMedGoogle Scholar
- Shott JP, McGrath SM, Pau MG, Custers JH, Ophorst O, Demoitie MA, Dubois MC, Komisar J, Cobb M, Kester KE, Dubois P, Cohen J, Goudsmit J, Heppner DG, Stewart VA: Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice. Vaccine. 2008, 26: 2818-2823. 10.1016/j.vaccine.2008.03.080.View ArticlePubMedGoogle Scholar
- Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, Perkins PV, Chumo DK, Koech DV, Whitmire RE, Roberts CR: Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg. 1994, 50: 529-536.PubMedGoogle Scholar
- Kilama WL: Ethical perspective on malaria research for Africa. Acta Trop. 2005, 95: 276-284. 10.1016/j.actatropica.2005.06.011.View ArticlePubMedGoogle Scholar
- Population and Housing Census. Retrieved Jul. 06, 2005, from Tanzania National Web site, 2002. [http://www.tanzania.go.tz/census/]
- Bodker R, Msangeni HA, Kisinza W, Lindsay SW: Relationship between the intensity of exposure to malaria parasites and infection in the Usambara Mountains, Tanzania. Am J Trop Med Hyg. 2006, 74: 716-723.PubMedGoogle Scholar
- Drakeley CJ, Carneiro I, Reyburn H, Malima R, Lusingu JP, Cox J, Theander TG, Nkya WM, Lemnge MM, Riley EM: Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. J Infect Dis. 2005, 191: 1589-1598. 10.1086/429669.View ArticlePubMedGoogle Scholar
- Lusingu JP, Jensen AT, Vestergaard LS, Minja DT, Dalgaard MB, Gesase S, Mmbando BP, Kitua AY, Lemnge MM, Cavanagh D, Hviid L, Theander TG: Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes. Infect Immun. 2006, 74: 2867-2875. 10.1128/IAI.74.5.2867-2875.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Bodker R, Akida J, Shayo D, Kisinza W, Msangeni HA, Pedersen EM, Lindsay SW: Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol. 2003, 40: 706-717.View ArticlePubMedGoogle Scholar
- Mnzava AE, Kilama WL: Observations on the distribution of the Anopheles gambiae complex in Tanzania. Acta Trop. 1986, 43: 277-282.PubMedGoogle Scholar
- Lusingu JP, Vestergaard LS, Mmbando BP, Drakeley CJ, Jones C, Akida J, Savaeli ZX, Kitua AY, Lemnge MM, Theander TG: Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania. Malar J. 2004, 3: 26-10.1186/1475-2875-3-26.PubMed CentralView ArticlePubMedGoogle Scholar
- Vyas S, Kumaranayake L: Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006, 21: 459-468. 10.1093/heapol/czl029.View ArticlePubMedGoogle Scholar
- Dirren H, Logman MH, Barclay DV, Freire WB: Altitude correction for hemoglobin. Eur J Clin Nutr. 1994, 48: 625-632.PubMedGoogle Scholar
- Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM: Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA. 2005, 102: 5108-5113. 10.1073/pnas.0408725102.PubMed CentralView ArticlePubMedGoogle Scholar
- Maxwell CA, Chambo W, Mwaimu M, Magogo F, Carneiro IA, Curtis CF: Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets. Malar J. 2003, 2: 28-10.1186/1475-2875-2-28.PubMed CentralView ArticlePubMedGoogle Scholar
- Alifrangis M, Lemnge MM, Ronn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC: Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Am J Trop Med Hyg. 2003, 69: 238-243.PubMedGoogle Scholar
- Robert V, Macintyre K, Keating J, Trape JF, Duchemin JB, Warren M, Beier JC: Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg. 2003, 68: 169-176.PubMedGoogle Scholar
- Keiser J, Utzinger J, Caldas dC, Smith TA, Tanner M, Singer BH: Urbanization in sub-saharan Africa and implication for malaria control. Am J Trop Med Hyg. 2004, 71: 118-127.PubMedGoogle Scholar
- Siri JG, Lindblade KA, Rosen DH, Onyango B, Vulule J, Slutsker L, Wilson ML: Quantitative urban classification for malaria epidemiology in sub-Saharan Africa. Malar J. 2008, 7: 34-10.1186/1475-2875-7-34.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.